Interferon γ regulates acute and latent murine cytomegalovirus infection and chronic disease of the great vessels

Journal of Experimental Medicine

Volumn 188, Issue 3, 1998, Pages 577-588

  Presti, Rachel M ^a   Pollock, Jessica L ^a   Dal Canto, Albert J ^a   O'Guin, Andrew K ^a   Virgin IV, Herbert W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytomegalovirus; Interferon ; Latency; Reactivation; Vasculitis

Indexed keywords

GAMMA INTERFERON;

ANIMAL MODEL; AORTITIS; ARTERITIS; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; HISTOPATHOLOGY; IMMUNE RESPONSE; LATENT PERIOD; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ACUTE DISEASE; ANIMALS; AORTITIS; CHRONIC DISEASE; HERPESVIRIDAE INFECTIONS; INTERFERON TYPE II; LUNG; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MUROMEGALOVIRUS; RECEPTORS, INTERFERON; SPLEEN; TIME FACTORS; VIRUS ACTIVATION; VIRUS LATENCY;

EID: 0032479923     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.3.577     Document Type: Article

References (54)

1. Nieto, F.J., E. Adam, P. Sorlie, H. Farzadegan, J.L. Melnick, G.W. Comstock, and M. Szklo. 1996. Cohort study of cytomegalovirus infection as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis. Circulation. 94:922-927.
2. Sorlie, P.D., E. Adam, S.L. Melnick, A. Folsom, T. Skelton, L.E. Chambless, R. Barnes, and J.L. Melnick. 1994. Cytomegalovirus/herpesvirus and carotid atherosclerosis: the ARIC study. J. Med. Virol. 42:33-37.
3. Melnick, J.L., E. Adam, and M.E. DeBakey. 1995. Cytomegalovirus and atherosclerosis. Bioessays. 17:899-903.
4. Koskinen, P., K. Lemstrom, C. Bruggeman, I. Lautenschlager, and P. Hayry. 1994. Acute cytomegalovirus infection induces a subendothelial inflammation (endothelialitis) in the allograft vascular wall. A possible linkage with enhanced allograft arteriosclerosis. Am. J. Pathol. 144:41-50.
5. Dummer, S., A. Lee, M.K. Breinig, R. Kormos, M. Ho, and B. Griffith. 1994. Investigation of cytomegalovirus infection as a risk factor for coronary atherosclerosis in the explanted hearts of patients undergoing heart transplantation. J. Med. Virol. 44:305-309.
6. McDonald, K., T.S. Rector, E.A. Braunlin, S.H. Kubo, and M.T. Olivari. 1989. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am. J. Cardiol. 64:359-362.
7. Grattan, M.T., C.E. Moreno-Cabral, V.A. Starnes, P.E. Oyer, E.B. Stinson, and N.E. Shumway. 1989. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA (J. Am. Med. Assoc.). 261:3561-3566.
8. Speir, E., R. Modali, E.-S. Huang, M.B. Leon, F. Shawl, T. Finkel, and S.E. Epstein. 1994. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science. 265:391-394.
9. Zhou, Y.F., M.B. Leon, M.A. Waclawiw, J.J. Popma, Z.X. Yu, T. Finkel, and S.E. Epstein. 1996. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N. Engl. J. Med. 335:624-630.
10. Yonemitsu, Y., K. Nakagawa, S. Tanaka, R. Mori, K. Sugimachi, and K. Sueishi. 1996. In situ detection of frequent and active infection of human cytomegalovirus in inflammatory abdominal aortic aneurysms: possible pathogenic role in sustained chronic inflammatory reaction. Lab. Invest. 74:723-736.
11. Tanaka, S., K. Komori, K. Okadome, K. Sugimachi, and R. Mori. 1994. Detection of active cytomegalovirus infection in inflammatory aortic aneurysms with RNA polymerase chain reaction. J. Vasc. Surg. 20:235-243.
12. Adler, S.P., J.K. Hur, J.B. Wang, and G.W. Vetrovec. 1998. Prior infection with cytomegalovirus is not a major risk factor for angiographically demonstrated coronary artery atherosclerosis. J. Infect. Dis. 177:209-212.
13. Gulizia, J.M., R. Kandolf, T.J. Kendall, S.L. Thieszen, J.E. Wilson, S.J. Radio, M.R. Costanzo, G.L. Winters, L.L. Miller, and B.M. McManus. 1995. Infrequency of cytomegalovirus genome in coronary arteriopathy of human heart allografts. Am J. Pathol. 147:461-475.
14. Kol, A., G. Sperti, J. Shani, N. Schulhoff, W. van de Greef, M.P. Landini, M. La Placa, A. Maseri, and F. Crea. 1995. Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation. 91:1910-1913.
15. Pauletto, P., G. Pisoni, R. Boschetto, M. Zoleo, A.C. Pessina, and G. Palu. 1996. Human cytomegalovirus and restenosis of the internal carotid artery. Stroke. 27:1669-1671.
16. Dangler, C.A., S.E. Baker, M.K. Njenga, and S.H. Chia. 1995. Murine cytomegalovirus-associated arteritis. Vet. Pathol. 32:127-133.
17. Reddehase, M.J., W. Mutter, K. Munch, H.J. Buhring, and U.H. Koszinowski. 1987. CD8-positive T lymphocytes specific for murine cytomegalovirus immediate-early antigens mediate protective immunity. J. Virol. 61:3102-3108.
18. + T lymphocytes. J. Exp. Med. 169:1199-1212.
19. Jonjic, S., I. Pavic, P. Lucin, D. Rukavina, and U.H. Koszinowski. 1990. Efficacious control of cytomegalovirus infection after long-term depletion of CD8+ T lymphocytes. J. Virol. 64:5457-5464.
20. Welsh, R.M., J.O. Brubaker, M. Vargas Cortes, and C.L. O'Donnell. 1991. Natural killer (NK) cell response to virus infections in mice with severe combined immunodeficiency. The stimulation of NK cells and the NK cell-dependent control of virus infections occur independently of T and B cell function. J. Exp. Med. 173:1053-1063.
21. Heise, M.T., and H.W. Virgin. 1995. The T cell independent role of IFN-gamma and TNF-alpha in macrophage activation during murine cytomegalovirus and herpes simplex virus infection. J. Virol. 69:904-909.
22. Orange, J.S., B. Wang, C. Terhorst, and C.A. Biron. 1995. Requirement for natural killer cell-produced interferon γ in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J. Exp. Med. 182:1045-1056.
23. Hengel, H., P. Lucin, S. Jonjic, T. Ruppert, and U.H. Koszinowski. 1994. Restoration of cytomegalovirus antigen presentation by gamma interferon combats viral escape. J. Virol. 68:289-297.
24. Gnbaudo, G., S. Ravaglia, A. Caliendo, R. Cavallo, M. Gariglio, M.G. Martinotti, and S. Landolfo. 1993. Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology. 197:303-311.
25. Lucin, P., S. Jonjic, M. Messerle, B. Polic, H. Hengel, and U.H. Koszinowski. 1994. Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumor necrosis factor. J. Gen. Virol. 75: 101-110.
26. Fennie, E.H., Y.S. Lie, M.A. Low, P. Gribling, and K.P. Anderson. 1988. Reduced mortality in murine cytomegalovirus infected mice following prophylactic murine interferon-gamma treatment. Antiviral Res. 10:27-39.
27. Lucin, P., I. Pavic, B. Polic, S. Jonjic, and U.H. Koszinowski. 1992. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J. Virol. 66:1977-1984.
28. + T-cell clones specifically activated by IE1 peptides in vitro. J. Virol. 70: 2162-2169.
29. Haagmans, B.L., P.H. van der Meide, F.S. Stals, A.J. van den Eertwegh, E. Claassen, C.A. Bruggeman, M.C. Horzinek, and V.E. Schijns. 1994. Suppression of rat cytomegalovirus replication by antibodies against gamma interferon. J. Virol. 68:2305-2312.
30. Soderberg-Naucler, C., K.N. Fish, and J.A. Nelson. 1997. Interferon-gamma and tumor necrosis factor a specifically induce formation of cytomegalovirus-permissive monocyte-derived macrophages that are refractory to the antiviral activity of these cytokines. J. Clin. Invest. 100:3154-3163.
31. Pollock, J.L., and H.W. Virgin. 1995. Latency, without persistence, of murine cytomegalovirus in spleen and kidney. J. Virol. 69:1762-1768.
32. Kurz, S., H.P. Steffens, A. Mayer, J.R. Harris, and M.J. Reddehase. 1997. Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J. Virol. 71:2980-2987.
33. Mayo, D., J.A. Armstrong, and M. Ho. 1978. Activation of latent murine cytomegalovirus infection: cocultivation, cell transfer, and the effect of immunosuppression. J. Infect. Dis. 138:890-896.
34. Mayo, D.R., J.A. Armstrong, and M. Ho. 1977. Reactivation of murine cytomegalovirus by cyclophosphamide. Nature. 267:721-723.
35. Baithesen, M., M. Messerle, and M.J. Reddehase. 1993. Lungs are a major organ site of cytomegalovirus latency and recurrence. J. Virol. 67:5360-5366.
36. Jonjic, S., I. Pavic, B. Polic, I. Crnkovic, P. Lucin, and U.H. Koszinowski. 1994. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. J. Exp. Med. 179:1713-1717.
37. Pollock, J.L., R.M. Presti, S. Paetzold, and H.W. Virgin. 1997. Latent munne cytomegalovirus infection in macrophages. Virology. 227:168-179.
38. Sherry, B., X.-Y. Li, K.L. Tyler, J.M. Cullen, and H.W. Virgin. 1993. Lymphocytes protect against and are not required for reovirus induced myocarditis. J. Virol. 67:6119-6124.
39. Muller, U., S. Steinhoff, L.F.L. Reis, S. Hemmi, J. Pavlovic, R.M. Zinkernagel, and M. Aguet. 1994. Functional role of type I and type II interferons in antiviral defense. Science. 264: 1918-1921.
40. Week, K.E., A.J. Dal Canto, J.D. Gould, A.K. O'Guin, K.A. Roth, J.E. Saffitz, S.H. Speck, and H.W. Virgin. 1997. Murine gamma-herpesvirus 68 causes large-vessel arteritis in mice lacking interferon-gamma responsiveness: a new model for virus-induced vascular disease. Nat. Med. 3:1346-1353.
41. Heise, M.T., J.L. Pollock, S.K. Bromley, M.L. Barkon, and H.W. Virgin. 1998. Murine cytomegalovirus infection suppresses interferon-gamma-mediated MHC class II expression on macrophages: the role of type I interferon. Virology. 241: 331-344.
42. MacDonald, M.R., X.Y. Li, R.M. Stenberg, A.E. Campbell, and H.W. Virgin IV. 1998. Mucosal and parenteral vaccination against acute and latent murine cytomegalovirus (MCMV) infection using an attenuated MCMV mutant. J. Virol. 72: 442-451.
43. Armas, J.C.G., C.S. Morello, L.D. Cranmer, and D.H. Spector. 1996. DNA immunization confers protection against murine cytomegalovirus infection. J. Virol. 70:7921-7928.
44. Jordan, M.C., and V.L. Mar. 1982. Spontaneous activation of latent cytomegalovirus from murine spleen explants: Role of lymphocytes and macrophages in release and replication of virus. J. Clin. Invest. 70:762-768.
45. Wise, T.G., J.E. Manischewitz, G.V. Quinnan, G.S. Aulakh, and F.A. Ennis. 1979. Latent cytomegalovirus infection of Balb/c mouse spleens detected by an explant culture technique. J. Gen. Virol. 44:551-556.
46. Cantin, E.M., D.R. Hinton, J. Chen, and H. Oppenshaw. 1995. Gamma interferon expression dunng acute and latent nervous system infection by herpes simplex virus type 1. J. Virol. 69:4898-4905.
47. Halford, W.P., B.M. Gebhardt, and D.J. Carr. 1996. Persistent cytokine expression in trigeminal ganglion latently infected with herpes simplex virus type 1. J. Immunol. 157: 3542-3549.
48. Heise, M.T., M. Connick, and H.W. Virgin IV. 1998. Murine cytomegalovirus inhibits interferon γ-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes. J. Exp. Med. 187:1037-1046.
49. Miller, D.M., B.M. Rahill, J.M. Boss, M.D. Lairmore, J.E. Durbin, J.W. Waldman, and D.D. Sedmak. 1998. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J. Exp. Med. 187:675-683.
50. Virgin, H.W., P. Latreille, P. Wamsley, K. Hallsworth, K.E. Week, A.J. Dal Canto, and S.H. Speck. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:5894-5904.
51. Rawlinson, W.D., H.E. Farrell, and B.G. Barrell. 1996. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70:8833-8849.
52. Koffron, A.J., M. Hummel, B.K. Patterson, S. Yan, D.B. Kaufman, J.P. Fryer, F.P. Stuart, and M.I. Abecassis. 1998. Cellular localization of latent munne cytomegalovirus. J. Virol. 72:95-103.
53. Hansson, G.K., M. Hellstrand, L. Rymo, L. Rubbia, and G. Gabbiani. 1989. Interferon-gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells. J. Exp. Med. 170: 1595-1608.
54. Geng, Y.-J., and G.K. Hansson. 1992. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J. Clin. Invest. 89: 1322-1330.